Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/29490
Tipo de documento
ArtigoDireito Autoral
Acesso restrito
Data de embargo
2028-08-30
Coleções
- INI - Artigos de Periódicos [3391]
Metadata
Mostrar registro completo
TELAPREVIR-BASED THERAPY IN PATIENTS COINFECTED WITH CHRONIC HEPATITIS C VIRUS INFECTION AND HIV: INSIGHT STUDY
Autor(es)
Afiliação
Servicio de Medicina Interna, Unidad de VIH, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Chelsea and Westminster Hospital, London, UK.
Hôpital St Antoine and INSERM, UMR S1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Warsaw Medical University and Hospital of Infectious Diseases, Warsaw, Poland.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Saint-Petersburg AIDS Center, St Petersburg, Russian Federation.
Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía/IMIBIC, Córdoba, Spain.
Infectious Diseases Department, L'Archet Hospital, University of Nice, Nice, France
Unidad de Enfermedades Infecciosas, Hospital General Universitario, Valencia, Spain.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Research & Development LLC, Titusville, NJ, USA
Servicio de Medicina Interna, Unidad de VIH, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Chelsea and Westminster Hospital, London, UK.
Hôpital St Antoine and INSERM, UMR S1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Warsaw Medical University and Hospital of Infectious Diseases, Warsaw, Poland.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Saint-Petersburg AIDS Center, St Petersburg, Russian Federation.
Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía/IMIBIC, Córdoba, Spain.
Infectious Diseases Department, L'Archet Hospital, University of Nice, Nice, France
Unidad de Enfermedades Infecciosas, Hospital General Universitario, Valencia, Spain.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Infectious Diseases BVBA, Beerse, Belgium.
Janssen Research & Development LLC, Titusville, NJ, USA
Servicio de Medicina Interna, Unidad de VIH, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Resumo em Inglês
INSIGHT (ClinicalTrials.gov NCT01513941) evaluated the efficacy, safety and pharmacokinetics of telaprevir-based therapy and specific antiretroviral agents in hepatitis C virus genotype 1 (HCV-1)/HIV-1-coinfected patients.
Compartilhar